SOMERSET, N.J., March 1 /PRNewswire-FirstCall/ -- Ventiv Health, Inc. today announced that Eran Broshy, Chief Executive Officer will make a presentation at the Lehman Brothers Ninth Annual Global Healthcare Conference taking place at the Loews Miami Beach Hotel in Miami March 8 - 10, 2006.
Ventiv's presentation will take place on Thursday, March 9 at 9:00 a.m. in the Poinciana 2 Room. A breakout session will be held immediately following the presentation in the Lucina Room. An audio webcast of the presentation can be accessed by logging on to http://www.ventiv.com/ir.asp
The Lehman Brothers conference will feature senior executive presentations for nearly 200 companies in the biotechnology, healthcare facilities, managed care, healthcare distribution and technology, medical supplies and devices, specialty pharmaceuticals, U.S. pharmaceuticals, European biotechnology and European pharmaceuticals categories. Attendees will receive unique insights and perspectives from the varied healthcare sectors represented in this exclusive forum. For more information on the agenda, please refer to the Lehman Brothers web site at http://www.lehman.com/conferences/2006GlobalHealth/agenda.html.
About Ventiv Health
Ventiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. Ventiv delivers its customized clinical, sales, marketing and communications services through its three core business segments: Ventiv Commercial, Ventiv Clinical and Ventiv Communications. Ventiv works with over 150 pharmaceutical and life sciences clients, including 18 of top 20 global pharmaceutical companies. For more information, visit http://www.ventiv.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments and revenue share agreements; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
Ventiv Health, Inc.CONTACT: Investors: John Emery, CFO, +1-732-537-4804, investor@ventiv.com;or Media: Felicia Vonella, +1-212-308-7155, fvonella@ventiv.com, both ofVentiv Health, Inc.
